DTL
MRNS

Dynamic Technology Lab’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Dynamic Technology Lab’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,051
Closed -$83K – 1509
2023
Q1 		$83K Buy
+12,051
New +$75.6K 0.01% 982
2020
Q3 		– Sell
-4,341
Closed -$44K – 1421
2020
Q2 		$44K Buy
+4,341
New +$39.9K 0.01% 925
2019
Q1 		– Sell
-5,949
Closed -$68K – 1403
2018
Q4 		$68K Buy
+5,949
New +$120K 0.01% 915
2018
Q3 		– Sell
-12,822
Closed -$363K – 1421
2018
Q2 		$363K Buy
+12,822
New +$284K 0.05% 592
2018
Q1 		– Sell
-4,491
Closed -$146K – 1442
2017
Q4 		$146K Buy
+4,491
New +$121K 0.03% 912

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Dynamic Technology Lab's MRNS Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2023, closing a stake of 12,051 shares — an estimated $83K sold.

Dynamic Technology Lab first reported a position in MRNS in Q4 2017 and held it in 5 quarters. The position peaked at $363K in Q2 2018. 106 funds tracked by Wall St. Rank hold MRNS as of Q2 2023.

  • Dynamic Technology Lab reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 12,051 Marinus Pharmaceuticals, Inc shares in Q2 2023, an estimated $83K.
  • Dynamic Technology Lab first reported a position in Marinus Pharmaceuticals, Inc in Q4 2017 and held it in 5 quarters.
  • Dynamic Technology Lab's Marinus Pharmaceuticals, Inc position peaked at $363K in Q2 2018.
  • 106 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.